Skip to content
VesTRAz0.0 Beta

Molecule lookup

VSTM2L in extracellular vesicles

Type a gene, protein, UniProt accession or microRNA, or a disease to see every molecule its studies reported. Every number you will see is a count of what published studies and their deposited samples have reported. Nothing on this page is predicted.

VSTM2L

VSTM2L (protein) in extracellular vesicles and exosomes: reported in 56 published studies and measured in 1,150 deposited samples, most often in tissue, cell culture medium. Every number links to the papers behind it. Free, no account.

First reported in 2008.

Isolation methods used: differential centrifugation, filtration, ultracentrifugation.

Conditions studied: Cholangiocarcinoma, Cystadenocarcinoma, Serous, Fallopian Tube Neoplasms, Glioblastoma.

Tumour tissue (CPTAC): measured in tumour tissue in 14 studies and normal adjacent tissue in 7 studies. Data generated by the National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC), from the NCI Proteomic Data Commons, CC BY 4.0.